1965
DOI: 10.2172/4590416
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Subcutaneous Implantation of Rare-Earth Metals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

1990
1990
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Further, injection of the contrast agent is an invasive technique that entails some risk. Gadolinium is deposited in the bone and other tissues (Gibby et al, 2004) and once in those tissues remains there for a long period of time (Talbot et al, 1965). Although the long-term effects of gadolinium are not known, there is cause for concern.…”
Section: Mitigation Of Motion-related Artifactsmentioning
confidence: 99%
See 1 more Smart Citation
“…Further, injection of the contrast agent is an invasive technique that entails some risk. Gadolinium is deposited in the bone and other tissues (Gibby et al, 2004) and once in those tissues remains there for a long period of time (Talbot et al, 1965). Although the long-term effects of gadolinium are not known, there is cause for concern.…”
Section: Mitigation Of Motion-related Artifactsmentioning
confidence: 99%
“…Although the long-term effects of gadolinium are not known, there is cause for concern. Gadolinium is one of the most potent inorganic calcium antagonists known (Biagi et al, 1990;Talbot et al, 1965), has carcinogenic effects (Rocklage et al, 1991;Costa, 1980), and may interfere with coagulation. Thus, repeated administrations of this contrast agent may be inadvisable.…”
Section: Mitigation Of Motion-related Artifactsmentioning
confidence: 99%
“…Lanthanide metals have been shown to induce neoplasms in mice (Talbot et al 1968;Ball et al 1970). However, the role of the rare earths in the pathogenesis of the observed tumors may be that of a promoter, enhancing the activity of an endogenous oncogenic agent, rather than an initiator.…”
Section: Systemic Toxicologymentioning
confidence: 99%
“…The anticoagulant properties of rare earths have been well documented in laboratory animals (Hunter and Walker 1956;Graca et al 1964;Talbot et al 1968), and anticoagulant therapeutic regimens have been attempted in man (baser et al 1942;Hunter and Walker 1956). However, the development of superior reagents of less toxicity has resulted in elimination of lanthanides from such application.…”
Section: Systemic Toxicologymentioning
confidence: 99%